Abrdn PLC Tarsus Pharmaceuticals, Inc. Transaction History
Abrdn PLC
- $51.7 Billion
- Q4 2024
A detailed history of Abrdn PLC transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Abrdn PLC holds 93,650 shares of TARS stock, worth $4.89 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
93,650
Previous 102,555
8.68%
Holding current value
$4.89 Million
Previous $3.37 Million
53.72%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding TARS
# of Institutions
188Shares Held
42.7MCall Options Held
484KPut Options Held
4.1K-
Rtw Investments, LP New York, NY3.41MShares$178 Million1.79% of portfolio
-
Black Rock Inc. New York, NY3.27MShares$171 Million0.0% of portfolio
-
Jennison Associates LLC2.5MShares$131 Million0.09% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.44MShares$127 Million2.89% of portfolio
-
Tang Capital Management LLC San Diego, CA2.25MShares$118 Million6.32% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.39B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...